SCHEMBL19397376

SCHEMBL19397376

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5cccc6ccccc56)cc4)nc(-c4ccc(-c5cccnc5)cc4)n3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.52
ALDH1A1 P00352 8/20 0.52
MAPT P10636 7/20 0.52
HPGD P15428 6/20 0.52
KDM4E B2RXH2 6/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
RAB9A P51151 2/20 0.52
DHODH Q02127 1/20 0.52
CYP19A1 P11511 2/20 0.50
CYP11B1 P15538 2/20 0.48
CYP17A1 P05093 1/20 0.47
CYP11B2 P19099 1/20 0.47
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NTSR1 P30989 1/20 0.44
TSHR P16473 3/20 0.44
GLA P06280 3/20 0.44
CYP2C9 P11712 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17918140 1.00 TNF (0.52) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL19528974 1.00 TNF (0.52) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL30296928 1.00 TNF (0.52) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL17917886 1.00 TNF (0.52) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL19637994 1.00 TNF (0.52) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL18725553 0.99 ALDH1A1 (0.53) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL29989130 0.99 ALDH1A1 (0.53) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL29776775 0.99 ALDH1A1 (0.53) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL23095094 0.96 DHODH (0.49) TNFALDH1A1MAPTHPGDKDM4E
SCHEMBL17917888 0.96 DHODH (0.49) TNFALDH1A1MAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM TNF 4824/4885ALDH1A1 129/4885MAPT 3242/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 TNF 4760/4885ALDH1A1 226/4885MAPT 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.